Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00143-1/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-8amY4OuxTG72uFa1uhE-bwe9VdkghaY_Xb1v-7MJEzbbHuoSiYfnYpIAPFTHK62yIe6gJtrPzQlvhLT0VWfXTinh787w&_hsmi=314709534&utm_content=314273834&utm_source=hs_email